DiaGenic ASA: Proposed Fully Underwritten Rights Issue

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OSLO--(BUSINESS WIRE)--Regulatory News:

The Board of DiaGenic ASA ("DiaGenic" or the "Company", ticker "DIAG")(OSE:DIAG) has resolved to propose that the Company carries out a new share issue of NOK 50 million, by way of a rights issue with preferential rights for shareholders of Diagenic (the "Rights Issue"). The Company has secured a full underwriting of the Rights Issue through an underwriting syndicate consisting of certain large existing shareholders of Diagenic, including Alfred Berg, Arkipel, MP Pensjon, Spar Kapital Investor, Storebrand Vekst, Corona Maritime, Gross Management, and Ferncliff Listed DAI. The underwriting has been made at NOK 0.50 per share, which will be the proposed subscription price in the Rights Issue.

Help employers find you! Check out all the jobs and post your resume.

Back to news